Prevention of Atrophic Nonunion Development by
Recombinant Human Bone Morphogenetic Protein-7

Takeshi Makino, David J. Hak, Scott J. Hazelwood, Shane Curtiss, A. Hani Reddi

University of California Davis
Severe periosteal and soft tissue disruption at the time of fracture may result in the
formation of an atrophic nonunion. We have developed a reproducible atrophic nonunion in an
animal model. The purpose of this study was to evaluate whether the immediate application of
recombinant human BMP-7 to the fracture site could rescue the healing process in this nonunion
model. A total of 56 three month old Fisher 344 rats were utilized. A 1.25mm diameter K-wire was
inserted into the femur in a retrograde fashion, and a mid-diaphyseal closed transverse fracture
was created using a standard three point bending device. To create a nonunion, the fracture site
was exposed and 2mm of the periosteum was cauterized on each side of the fracture. The fracture
site was immediately treated with either the application of rhBMP-7 5Oμl in 25μl of rat tail tendon
collagen buffer (BMP-7 group), or with 25μl of rat tail tendon collagen buffer only(Control group).
Fracture healing was evaluated with serial radiographs every two weeks for an eight weeks period.
Specimens at four and eight weeks were subjected to biomechanical and histological evaluation.
None of the Control group healed throughout the eight weeks experimental duration. At four weeks
63% of the BMP-7 group had healed, and all had healed by six weeks. This investigation showed
pronounced differences between the BMP-7 group and the Control group both histologically and
biomechanically. In conclusion, we have demonstrated that the immediate application of BMP-7
may rescue the fracture healing process and prevent the development of nonunion following severe
periosteal disruption.

Introduction
Clinical and experimental evidence of healed frac-tures has highlighted the importance of
minimizing periosteal disruption at the fracture site [5,15,17,20, 21,25]. During an initial
stage of fracture healing, the periosteal cells first differentiate into osteoblasts fol-lowed by
intramembranous ossification [3]. Severe periosteal and soft tissue disruption at the time
of fracture may result in atrophic nonunion. We have devel-oped a reproducible nonunion
model in the rat femur that simulates the clinical condition in which there is periosteal
disruption without segmental bone defect, and showed pronounced differences between
the experi-mental nonunions and the standard closed fractures both histologically and
biomechanically [14].
Bone morphogenetic proteins (BMPs) govern the key steps in new bone formation
[23,24]. BMP-7 has been shown to act on the proliferation and differentiation of
osteoprogenitor cells into bone forming cells [2]. The therapeutic potential of recombinant

human BMP-7 (rhBMP-7) has been examined in animal models of critical-sized segmental
bone defects, osteochondral defects, spinal fusion, and distraction osteogenesis
[8,16,18,19]. Some clinical studies have also been performed on tibia1 nonunions and
fibular defects [lo, 111. The purpose of this study was to evaluate whether immediate
application of rhBMP-7 to the fracture site could rescue the healing process and prevent
nonunion formation following severe periosteal disruption.

Materials and methods
Experimental design
Fifty-six male 3 months old Fisher 344 rats were included in this study. Their mean
and standard deviation of body weight was 298g (standard deviation ±14g). All surgical
procedures were performed under general anesthesia and normal sterile conditions.
Anesthesia was performed with 4% Halothane inhalation, followed by Ketamine
hydrochloride (80mg/kg) and Xylazine hydrochloride (8mg/kg) administered
intraperitoneally.
A lateral parapatellar knee incision on the right limb was made to expose the distal
femoral condyle. A 1.25mm diameter K-wire was inserted from the trochlear groove into
the femoral canal in a retrograde fashion with use of a motor-driven drill. The wire was
advanced through the greater trochanter and out of the skin until its distal end was
positioned deep to the articular surface of the knee. A 5mm incision in the skin was made
around the K-wire and the wire was then cut close to the proximal femur. After irrigation
with sterile saline, the wounds were closed with 5-0 nylon suture. A closed transverse
femoral shaft fracture was then created in the right femur of each rat using a three point
bending apparatus with a drop weight (R. Zarb, State University New York, Brooklyn, NY,
USA) following the method of Bonnarens and Einhorn [4]. Following this procedure, all of
the rats received additional surgery to create a nonunion in the fractured shaft. In order to
produce the nonunion, the fractured site was exposed through a lateral approach, and the
periosteum was cauterized (Loop tip surgical cautery, Abco Dealers Inc., Nashville, TN,
USA) circumferentially for a distance of 2mm on each side of the fracture. The muscle was
protected to preserve all soft tissue except the periosteum around the fracture site. The
wound was then irrigated with 10cc of sterile saline and the wound was dried with gauze.
Radiographs were obtained immediately post-operatively to confirm fracture
configuration and K-wire placement. Four animals had comminuted fractures and one
developed an infection. These animals were eliminated from the study and replaced. All of
the remaining fractures were mid-diaphyseal transverse fractures. With the exception of

the animal with the infection all of the wounds healed uneventfully. No increase in local
swelling was observed in the BMP treated animals.
Animals were randomized into two groups of 28. One group was treated with
rhBMP-7 50 pg in 25 pl of rat tail tendon collagen buffer (BMP-7 group), and the other
group was treated with 25pl of rat tail tendon collagen buffer only (Control group). The
concentration of rat tail tendon collagen buffer was O.1Smglml in 50mM acetic acid. The
rhBMP-7 or the collagen buffer alone was carefully applied anteriorly, laterally, and
posteriorly to the experimental nonunion site with a pipet. The viscosity of the collagen
buffer prevented extravasation into the surrounding soft tissues. The muscle fascia and
skin were closed in layers with 5-0 nylon sutures. Post-operative pain was managed by
administration of subcutaneous injection of buprenorphine hydrochloride after surgery.
The rats were fed a standard maintenance diet and provided water ad libitum. Unprotected
weight bearing was allowed immediately post-operatively.
Four animals from each group were euthanized with an excess of carbon dioxide gas
at two weeks and underwent histological evaluation. Twelve animals from each group were
maintained for intervals of 4 and 8 weeks. Eight specimens from each time point were
randomly selected for biomechanical testing as described below at 4 and 8 weeks. The four
remaining specimens from each group were processed for histological study. This research
protocol was approved by the Institutional Animal Care and Use Committee, following all
appropriate guidelines.

Radiological evaluation
The progress of bone formation was monitored on radiographs (model 43855A;
Faxitron X-ray, Buffalo Grove, IL, USA). Radiographs of all rats were obtained following
immediately after surgery and at 2 week intervals until the time of sacrifice. This was done
under anesthesia with the animal prone and both limbs fully abducted and external
rotated. Radiographs of each animal were assessed by three blinded independent
observers to judge whether the fractures united or not. Fracture union was determined by
the presence of a bridging callus on two cortices. Concordance of the three observers was
required. When the reviewers differed in their interpretation the classification of healed
versus nonhealed was made by group consensus.

Histological evaluation

Histological evaluation was performed on four animals from each group at 2, 4 and
8 weeks after surgery. Right femurs were harvested and fixed in 4% paraformaldehyde in
0.1 M phosphate buffer for 24h at 4°C, defatted in 70% ethanol, decalcified with 10%
formic acid in citrate for 4days at 4°C and embedded in paraffin. Paraffin sections 4pm
thick were cut and stained with toluidine blue for histological evaluation. The degree of
fracture healing was evaluated using a five point scale proposed by Allen et al. [I] According
to this classification system grade four represents complete bony union, grade three
represents an incomplete bony union (presence of a small amount of cartilage in the
callus), grade two represents a complete cartilaginous union (well-formed plate of hyaline
cartilage uniting the fragments), grade one represents an incomplete cartilaginous union
(retention of fibrous elements in the cartilaginous plate), and grade zero indicates the
formation of a pseudoarthrosis (most severe form of arrest in fracture repair).

Biomechanical evaluation
Biomechanical evaluation was performed on eight animals from each group at 4 and
8 weeks. Following euthanasia the right femurs and the contralateral nonfractured intact
femurs were harvested and dissected free of surrounding muscles. After removal of the
intramedullary K-wires, the ends of both femurs were imbedded in Wood's metal (Alfa
Aesar, Ward Hill, MA, USA). Specimen length was statistically similar between the BMP-7
group (17.5 ± 1.9mm) and the Control group (17.2 ± 1.7mm) (p, > 0.05). The specimens
were mounted in a Frankel-Burstein axial torsion-testing machine [6] that was modified to
operate under computer control. The standard swinging-pendulum mechanism was
replaced with an electronic stepper motor drive (model 083062-1-8-03 1-010, Parker
Compumotor, Rohnert Park, CA, USA). Rotational displacement was measured with a
precision potentiometer (model 793341-14092, Gould. Inc., Cleveland, OH, USA), and
torque was measured with a torque cell (model 2105, Eaton Corporation, Troy, MI, USA).
Specimens were tested in torsion at a rate of 50° per minute until failure or through an arc
of 45°. Rotational displacement and torque data were collected at 60Hz using a digital data
acquisition system (model K500A, Keithley Instruments, Cleveland, OH, USA). Maximum
torque to failure was measured directly from the data and torsional stiffness was calculated
from a regression of the linear portion of the torque versus angular displacement curve.
The energy absorption to maximum torque was calculated as the area under the curve to
the maximum value. The contralateral intact femur was also tested to calculate normalized
values of maximum torque to failure (percent maximum torque), stiffness (percent
stiffness) and energy absorption to maximum torque (percent energy) in order to reduce
the influence of individual animal differences.

Statistical analysis
A two factor analysis of variance (ANOVA) was performed on the values of the
biomechanical properties. The factors were the time point and the experimental model
(BMP-7 group, Control group and Intact group). Second, ANOVA was performed on the
normalized data of the biomechanical properties (BMP-7 group and Control group) to ac
count for individual animal differences. Significance was defined as p values less than 0.05.
When appropriate, a Bonferroni-Dunn post hoc test was performed to determine
differences between the models at the various time points. For the post hoc test, the level of
signifi-cance was adjusted to 0.0018 to account for multiple comparisons.
Results
Radiological evaluation
Radiographs taken just after surgery showed trans-verse mid-diaphyseal femoral
fractures in both the BMP-7 group and the Control group (Fig. 1A, E). The numbers of
radiographic fracture unions during each period were shown in Table 1. Sixty-three
percent of the BMP-7 group healed at 4 weeks, and they all healed at 6 weeks after
surgery. In contrast, bridging callus was not seen in the Control group, even at 8 weeks
after surgery, with 10 of 12 specimens classified as atrophic nonunions based on their
radiographic appearance (Fig. 1H). The radiographic findings were inconclusive in two of
the Control group, but their bio-mechanical properties confirmed the development of a
nonunion. The BMP-7 group displayed abundant callus around the fracture sites at two
weeks (Fig. 1B). At 4 weeks, most of the callus bridged between both ends of the
fractured bones and the cortical gaps disappeared (Fig. IC). After forming a bridging
callus, bone remod-eling and consolidation began (Fig. 1 D). No evidence of heterotopic
ossification was observed in the surrounding soft tissues of any of the BMP-7 treated
specimens. On the other hand, the Control group did not have much callus fonnation
around the fracture sites. Some callus formed along the periosteum away from the
fracture site, but this never extended to bridge the fracture site (Fig. 1 F, G). The ends of
the fractured bone became round and were resorbed, appearing to be established
nonunions at 8 weeks (Fig. 1H).
The largest area of callus was observed posterior to the femur. The collagen and
BMP was applied uni-formly to the anterior, lateral and posterior aspect of the fracture.
Although extravasation of the material was not seen acutely, this larger area of posterior
callus may represent gradual flow of BMP and collagen into the dependent region
following the surgical procedure.
Histological evaluation

At 2 weeks, the BMP-7 group displayed intramem-branous ossification in the
periosteal tissue and newly formed trabecular bone at the fracture site (Fig. 2A). Newly
formed trabecular bone was predominant corn-ponent of this thick callus. At 2 weeks,
the Control group exhibited chondrocytes and nonbridging endo-chondral ossification
(Fig. 2D), but there was no bone formation on the site of periosteal cauterization. At four
weeks after surgery, the callus in the BMP-7 group had united and the chondrogenic
areas had disappeared (Fig. 2B). The fractured bone was covered with newly formed
trabecular bone and achieved bony union. In contrast, a large gap persisted between the
surfaces of woven bone in the Control group at four weeks (Fig. 2E). At eight weeks, the
united bone in the BMP-7 group had remodeled with progressive decrease in the
thickness of the woven bone (Fig. 2C). In comparison, at 8 weeks in the Control group,
the fibrous tissue was interposed at the fracture site and the ends of the frac-tured bone
became round and resorbed (Fig. 2F). This is consistent with the histological finding of
atrophic nonunions.
In the Control group, histological grading of the frac-ture healing was similar
among all specimens within each time-point. Histology of controls was graded as 1 at
week 2, and 0 at weeks 4 and 8. In the BMP-7 treated specimens the mean histology
grade was 1.5 at week 2, and 4 at weeks 4 and 8.
Biomechanical evaluation
The means and standard deviations of the maximum torque to failure, the
stiffness and the energy absorp-tion to maximum torque are shown in Table 2. The
maximum torque, stiffness and energy absorption values were normalized by the
respective values from the intact femurs (percent maximum torque, percent stiffness and
percent energy) and average values were calculated for each group (Fig. 3). Significant
increase in all the mechanical properties was seen in the BMP-7 group compared to the
Control group at both 4 and 8 weeks. No significant difference in all the mechanical
properties was seen between the BMP-7 group and the Intact group at both 4 and 8
weeks. All the mechanical properties of the BMP-7 group gradually increased between at
4 and 8 weeks, but no significant differences between 4 and 8 weeks was seen in all the
mechanical properties. The mean values of percent maximum torque at 8 weeks and
percent energy at 4 and 8 weeks of the BMP-7 group exceeded 100% (Fig. 3A, C). All the
mechanical properties of the Control group were less than 25% of their corresponding
intact values at 4 and 8 weeks (Fig. 3).
Discussion
Most previous studies have evaluated the effect of BMP treatment in criticalsized segmental defects [8,13,26]. However, these models may not adequately simulate

the biological and mechanical environment that clinically leads to nonunion
development. Our model was specifically developed to better simulate the altered
biological and mechanical environment that is seen in high energy fractures. In high
energy fractures, there is often significant disruption of periosteum and surrounding
soft tissues [12]. Clinical and experimental evidence indicates that periosteal disruption
at the frac-ture site impairs fracture healing [5,15,17].
The present study demonstrated that immediate application of rhBMP-7 into the
fracture site enhances the fracture healing process of this nonunion model in radiographic,
histological and biomechanical properties. Serial radiographs indicated that 63% of the
BMP-7 treated group united radiographically at 4 weeks and at 6 weeks all displayed
bridging callus indicating a uni-ted fracture. In contrast, the cauterized nonunion model did
not heal by 8 weeks after fracture. Our radiograph-ical findings of the BMP-7 treated group
at 2 weeks revealed a large amount of callus. Histologically this callus already consisted
mainly of newly formed trabecular bone, with few small chondrogenic areas. In contrast, a
nonbridging cartilaginous callus was present in the nonunion group at 2 weeks. It is known
that BMPs act at an early stage of bone induction. They induce, promote and maintain both
bone and cartilage formation [22]. Recently it has been reported single injection of high
dose rhBMP-2 into the standard rat fracture model induced a large amount of fracture
callus and enhanced fracture healing [9]. Significant periosteal and soft tissue disruption
occurs in open tibia fractures, which are often complicated by delayed union and nonunion.
Serial debridement of open fractures may cause additional periosteal damage and further
resection of necrotic or contaminated tissues may be required. Application of rhBMP-2 (1.5
mg/ml) at the time of open fracture wound closure has been shown to accelerate fracture
healing and reduce the frequency and invasive-ness of secondary interventions to achieve
union in hu-mans [12]. Similarly in our study, the application of BMP appears to accelerate
endochondoral bone formation, rapidly converts cartilaginous callus to bone, even in the
presence of severe periosteal disruption. In contrast, in the absence of supplemental BMP
there is resorption of the fracture ends with interposition of the fibrous tissue.
Biomechanical torsional testing revealed that percent maximum torque was six
times larger, percent stiffness was eleven times larger, and percent energy was ten times
larger for the BMP-7 treated group compared to the nonunions at 8 weeks. Each of these
mechanical properties had statistically significant differences between the BMP-7 treated
group and nonunion group. The nonunions did not have the remodeling callus around the
fracture site and the two fractured fragments were connected with only fibrous tissue,
making the nonunion weaker than the BMP-7 treated group throughout the study. The
biomechanical evaluation supported the radiographic and histological findings of the
fracture repair by rhBMP-7.
The Control groups used in this study were treated with 25 μl of collagen applied

to the fracture site at the time of cauterization. The mechanical results of these collagen
treated controls are comparable to the results seen in our previously reported study in
which nothing was applied following cauterization [14]. In that study, the mean
maximum torque to failure in animals treated with cauterization alone was 0.052 Nm at
4 weeks, and 0.088 Nm at 8 weeks. This indicates that the enhanced bone healing seen
in this study was due to the rhBMP-7 rather than the collagen carrier.
A dose response study was not performed to deter-mine the optimal rhBMP-7
dosage to promote bone formation in this model. The amount selected, 50 .tg, was based on
successful union reported in a rat segmen-tal femoral defect model [7]. That study also
reported the use of a smaller dose, 11 μg, however the amount of bone formation was not
as great with the lower dose. In a recently published report of percutaneous rhBMP-2
injection in a closed femur fracture model, an even higher dose, 80 μg, has been used [9].
We have shown the immediate application of rhBMP-7 may rescue the healing
process and prevent the development of nonunion. The present study dem-onstrates
rhBMP-7 has the potential to accelerate the healing process of the high energy fractures
in clinical situations.
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Fig. I. Radiographs of both the BMP-7 group (A-D) and the Control group (E-HI obtained immediately after surgery (A, E), 2 weeks after surgery
(B, F), 4 weeks after surgery (C, 0). and 8 weeks after surgery (D. H). Note the union in the BMP-7 group and the gap in the Control group.

Table I
Serial radiographic evaluation of fracture union
Period after surgery (weeks)

2
4
6
8

Control group
0128 (0%)
15/24 (63%)
12112 (100%)
12112 (I OOY,)

0/28 (0%)

0124 (0%)
0112 (0%)

0112 (0%)

-

c

1mm

Fig. 2. Histological findings of the 8MP·? group (A-e) and the Control group CD-F). Sections were stained with toluidine blue. The 8MP-? group
al 2 weeks displayed newly fonned trdbecular bone at the fracture site (A). The Control group exhibited chondrocyle5 and non bridging endochondral
ossification (D). The 8MP-? group united al 4 weeks after surgery (B). The Control group still had a large gap (E). At 8 weeks. the united bone had
remodeled (C). No healing was observed and the cortical bone was resorbed (F). en; endochondral ossification. co; cortical bone. Bar, 1rom.

Table 2
Biomechanical evaluation in 8MP-? group, Control group and Iniac! group
8Mp·? group·

Control groupa

lotace

Maximum torque to failure / Nm J

4 weeks
8 weeks

0.409

± 0.108'

0.041 :!: 0.028
0.069 ± 0.046

0.278 ± 0.051
0.333 ± 0.052

Stiffness I NmlradJ
4 weeks
8 weeks

0.840 ± 0.284'
1.]7] ± 0.]]6'

0.123 ± 0.093
0.117 ± 0.023

1.020 ± 0.144
1.392 :!: 0.164

0.249 ± 0.065'

Energy absorption to maximum torque [NmrudJ
4 weeks
0.0623 ± 0.0361"
8 weeks
0.0830 ± 0.0417'

0.0065 ± 0.0044
0.0078 ± 0.0062

No significant dilTerence of the values between in the BMP-7 group and in the Intact group (p > 0.05).
, Significanlly greater than the values in the Control group (p < 0.0001).
.. Significantly greater than the values in the Control group (p = 0.00(7).
• The values are given as the mean and standard deviation.

0.0474

± 0.0159

0.0554 ± 0.0226
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Fig. 3. Biomechanical properties of the BMP-7 group and the Control
group normalized by the respective values of the intact femufs. (A)
Percent maximum torque (maximum torque to failure of fractured
femur/nonfraclured intact femuf x tOO). (B) Percent stiffness (stiffness
of fractured femur/nonfractured intact femuf x 1(0). (C) Percent
energy (energy absorption to maximum lOfquelnonfractured intact
femUf x 100). ·Significanl differences were found between the Control
group and the BMP-? group in percent maximum torque. percent
stiffness, and percent energy measurements (p < 0.0001).

